Showing results (141-150 of 175) with videos related to

Sort By:
Pageof 18
Nature Communications|May 9, 2020
Somatic mTOR mutation in clonally expanded T lymphocytes associated with chronic graft versus host diseaseDaehong Kim, Giljun Park, Jani Huuhtanen, et al.
Blood Advances|July 8, 2018
Telomere shortening correlates with leukemic stem cell burden at diagnosis of chronic myeloid leukemiaAnne-Sophie Bouillon, Monica S Ventura Ferreira, Shady Adnan Awad, et al.
The Journal of Clinical Investigation|September 1, 2022
IFN-α with dasatinib broadens the immune repertoire in patients with chronic-phase chronic myeloid leukemiaJani Huuhtanen, Mette Ilander, Bhagwan Yadav, et al.
The Journal of Allergy and Clinical Immunology|January 25, 2017
Damaging heterozygous mutations in NFKB1 lead to diverse immunologic phenotypesMeri Kaustio, Emma Haapaniemi, Helka Göös, et al.
Cancer Discovery|November 18, 2021
Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid LeukemiaDisha Malani, Ashwini Kumar, Oscar Brück, et al.
Blood|May 15, 2008
Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome-positive leukemiaKimmo Porkka, Perttu Koskenvesa, Tuija Lundán, et al.
Blood|August 9, 2013
STAT3 mutations indicate the presence of subclinical T-cell clones in a subset of aplastic anemia and myelodysplastic syndrome patientsAndres Jerez, Michael J Clemente, Hideki Makishima, et al.
Cancer Research|October 30, 2025
Multi-omics Profiling of T-cell Leukemia and Lymphoma Enables Targeted Therapeutic DiscoveryAleksandr Ianevski, Kristen Nader, Julia Nguyen, et al.
Biorxiv : the Preprint Server for Biology|April 27, 2026
Multimodal immunopharmacologic screens identify drugs rewiring the cancer-immune interfaceJonas Bouhlal, Emmi Jokinen, Petra Nygren, et al.
Blood|June 21, 2011
Combination of pegylated IFN-α2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemiaBengt Simonsson, Tobias Gedde-Dahl, Berit Markevärn, et al.
Pageof 18